Glutamine

huntingtin ; Homo sapiens







114 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32235053 The phasor FLIM method reveals a link between a change in energy metabolism and mHtt protein spread in healthy Mammalian cells when co-cultured with Huntington diseased cells. 2021 Jan 11 2
2 32995988 DYNLT1 gene expression is downregulated in whole blood of patients at different Huntington's disease stages. 2021 May 1
3 33070471 Altered third-party punishment in Huntington's disease: A study using neuroeconomic games. 2021 Jan 1
4 33827396 Cardio-Vascular Heat Shock Protein (cvHsp, HspB7), an Unusual Representative of Small Heat Shock Protein Family. 2021 Jan 1
5 33920936 Emerging Roles of Exosomes in Huntington's Disease. 2021 Apr 15 1
6 34201610 Membrane Interactions Accelerate the Self-Aggregation of Huntingtin Exon 1 Fragments in a Polyglutamine Length-Dependent Manner. 2021 Jun 23 1
7 34831058 The Cytotoxicity and Clearance of Mutant Huntingtin and Other Misfolded Proteins. 2021 Oct 21 1
8 34880419 Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1. 2021 Dec 8 3
9 32341997 Live-Cell Imaging and Quantification of PolyQ Aggregates by Stimulated Raman Scattering of Selective Deuterium Labeling. 2020 Apr 22 1
10 32402249 Flanking Regions Determine the Structure of the Poly-Glutamine in Huntingtin through Mechanisms Common among Glutamine-Rich Human Proteins. 2020 Jul 7 1
11 33224521 New developments in Huntington's disease and other triplet repeat diseases: DNA repair turns to the dark side. 2020 Dec 2
12 30672003 Structural insights into the aggregation mechanism of huntingtin exon 1 protein fragment with different polyQ-lengths. 2019 Jun 1
13 30842263 Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems. 2019 Apr 26 1
14 31226569 MnFe2O4 nanoparticles accelerate the clearance of mutant huntingtin selectively through ubiquitin-proteasome system. 2019 Sep 2
15 31297710 Quality Control in Huntington's Disease: a Therapeutic Target. 2019 Oct 2
16 31398342 CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset. 2019 Aug 8 1
17 29359503 A General Strategy to Access Structural Information at Atomic Resolution in Polyglutamine Homorepeats. 2018 Mar 26 2
18 29377621 Potassium channel dysfunction in neurons and astrocytes in Huntington's disease. 2018 Apr 2
19 29601786 Self-assembly of Mutant Huntingtin Exon-1 Fragments into Large Complex Fibrillar Structures Involves Nucleated Branching. 2018 Jun 8 1
20 30279700 SUMO-Targeted Ubiquitin Ligases (STUbLs) Reduce the Toxicity and Abnormal Transcriptional Activity Associated With a Mutant, Aggregation-Prone Fragment of Huntingtin. 2018 1
21 27514446 Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility. 2017 Feb 19 2
22 28674979 Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets. 2017 1
23 28968242 Huntington's Disease and Diabetes: Chronological Sequence of its Association. 2017 1
24 26350150 Delayed emergence of subdiffraction-sized mutant huntingtin fibrils following inclusion body formation. 2016 Jan 1
25 26601664 Inhibition of Early Biochemical Defects in Prodromal Huntington's Disease by Simultaneous Activation of Nrf2 and Elevation of Multiple Micronutrients. 2016 1
26 26846325 Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly. 2016 May 1
27 26863614 Dominant-Negative Effects of Adult-Onset Huntingtin Mutations Alter the Division of Human Embryonic Stem Cells-Derived Neural Cells. 2016 1
28 24048953 Large Animal Models of Huntington's Disease. 2015 1
29 25687118 Expansion of CAG triplet repeats by human DNA polymerases λ and β in vitro, is regulated by flap endonuclease 1 and DNA ligase 1. 2015 May 1
30 25761110 Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model. 2015 1
31 25995452 Structural Mechanisms of Mutant Huntingtin Aggregation Suppression by the Synthetic Chaperonin-like CCT5 Complex Explained by Cryoelectron Tomography. 2015 Jul 10 1
32 26195796 Huntington's disease: Neural dysfunction linked to inositol polyphosphate multikinase. 2015 Aug 4 1
33 26210848 Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease. 2015 Dec 3
34 26673834 A protein polymerization cascade mediates toxicity of non-pathological human huntingtin in yeast. 2015 Dec 17 2
35 24184605 Nucleolar dysfunction in Huntington's disease. 2014 Jun 2
36 24415136 Atomistic mechanisms of huntingtin N-terminal fragment insertion on a phospholipid bilayer revealed by molecular dynamics simulations. 2014 Jul 1
37 24968783 The role of dopamine in Huntington's disease. 2014 1
38 25316320 Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances. 2014 Dec 5 2
39 25358787 Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells. 2014 Oct 14 2
40 25723022 [Huntington's disease: cellular and molecular basis of pathology]. 2014 Jul-Aug 2
41 23423362 Role of cerebral cortex in the neuropathology of Huntington's disease. 2013 1
42 23612654 The unresolved puzzle why alanine extensions cause disease. 2013 Aug 1
43 23819039 Factors Affecting Aggregate Formation in Cell Models of Huntington's Disease and Amyotrophic Lateral Sclerosis. 2013 Apr 1
44 23847583 A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation. 2013 1
45 24006238 Epigenetic mechanisms of neurodegeneration in Huntington's disease. 2013 Oct 1
46 24330821 Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. 2013 Dec 11 1
47 25063429 A transgenic minipig model of Huntington's Disease. 2013 1
48 22052286 An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors. 2012 Feb 1 1
49 22200539 Protein aggregates in Huntington's disease. 2012 Nov 1
50 22773688 Raft-like microdomains play a key role in mitochondrial impairment in lymphoid cells from patients with Huntington's disease. 2012 Oct 2